Position in RNXT
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$6,174
-$189 QoQ
Shares Held
6,300
0.0% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#5
of 6 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RNXT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Midway Capital Research & Management holds $6,174 across 1 Biotechnology name. RNXT ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RNXT |
RenovoRx, Inc.
This page
|
6,300 | $6,174 |
All Filings in RNXT
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,174 | 6,300 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $6,363 | 6,300 | Shares | Sole | 2026-04-13 | |
| No filing history on record for this holder in this stock. | ||||||